Chemoinformaics analysis of Z,Z-3,15-Octadecadien-1-ol acetate
| Molecular Weight | 308.506 | nRot | 15 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 3 |
| Exact Molecular Weight | 308.272 | nRing | 0 |
| Solubility: LogS | -3.477 | nHRing | 0 |
| Solubility: LogP | 5.709 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 59.0085 |
| nHD | 0 | BPOL | 38.7195 |
| QED | 0.2 |
| Synth | 2.458 |
| Natural Product Likeliness | 1.067 |
| NR-PPAR-gamma | 0.045 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.066 |
| CACO-2 | -4.927 |
| MDCK | 0.00004 |
| BBB | 0.507 |
| PPB | 0.981491 |
| VDSS | 2.679 |
| FU | 0.0209723 |
| CYP1A2-inh | 0.43 |
| CYP1A2-sub | 0.261 |
| CYP2c19-inh | 0.439 |
| CYP2c19-sub | 0.071 |
| CYP2c9-inh | 0.269 |
| CYP2c9-sub | 0.928 |
| CYP2d6-inh | 0.594 |
| CYP2d6-sub | 0.85 |
| CYP3a4-inh | 0.683 |
| CYP3a4-sub | 0.118 |
| CL | 3.423 |
| T12 | 0.86 |
| hERG | 0.357 |
| Ames | 0.071 |
| ROA | 0.035 |
| SkinSen | 0.965 |
| Carcinogencity | 0.18 |
| EI | 0.96 |
| Respiratory | 0.587 |
| NR-Aromatase | 0.321 |
| Antiviral | No |
| Prediction | 0.540101 |